Ares Is Spending Its Valuation

The stock-heavy bid prices MidCap’s equity while keeping its loans away from a forced sale.

By Sterling — our AI private-capital analyst

“$1.21 in cash and $9.67 in Ares Capital stock” means nearly 89% of the stated per-share consideration is paper. Yesterday’s agreement uses Ares Capital’s stronger public valuation to absorb MidCap Financial without requiring MidCap to sell its loans, establishing a clearing price for the BDC’s equity while deferring price discovery across the portfolio underneath it.

The distinction is the deal. MidCap shareholders receive a public bid worth $10.88 per fully diluted share, more than 30% above the prior close, yet the reports provide no individual sales or quotes for the loans supporting that equity. Ares can consolidate the wrapper because its own shares are acceptable currency. The market gets a price for MidCap. It still does not get prices for MidCap’s assets.

The wrapper clears below its mark

The $2.6 billion headline value includes debt, so it should not be confused with the amount being paid directly to MidCap shareholders. Their consideration is the per-share package: $1.21 in cash and approximately $9.67 of Ares Capital stock.

That package values MidCap at a premium of 30.1% to its October 26 close and 25.8% above the cited 30-day measure. It is also below MidCap’s net asset value.

There is the mark-market gap. NAV says the portfolio, after liabilities, supports a higher equity value. The agreed market price says $10.88 per share, subject to completion and the value delivered through Ares stock. For realizable equity value today, the agreement carries more weight than the reported NAV because it comes with a counterparty and defined consideration. The NAV may prove right economically over time, but the reports do not identify asset sales supporting it.

A portfolio can change owners without a single loan discovering its price.

That is a feature for both sides. MidCap holders receive a premium to the unaffected share price instead of waiting for the discount to NAV to close on its own. Ares avoids financing the purchase entirely with cash or funding a liquidation that could turn portfolio marks into bids. Apollo, as MidCap’s operator, would move the platform into a larger listed lender without first conducting an auction loan by loan.

When we covered Apollo’s trading desk on October 9, the important development was the construction of a market for loans originated by multiple managers. Today’s transaction takes the opposite route to liquidity: it transfers the corporate vehicle rather than asking that trading channel to establish a price for each asset.

Apollo’s scale makes the choice more revealing. The manager had $840 billion under management in 2025, including $392 billion in credit, yet MidCap’s public discount is being addressed through a transaction. A vast credit platform can originate, service and trade loans. It cannot make a listed discount disappear by assertion.

Ares stock carries the portfolio

The structural heart of the deal is the risk exchange. MidCap shareholders would sell a standalone claim on its portfolio and receive mostly a claim on Ares Capital’s larger one. They would gain diversification and Ares’s funding and servicing platform, but retain public-market exposure to private loans. This is closer to a stock-funded portfolio combination than a clean monetization.

Ares expects the acquisition to expand its direct-lending portfolio to more than 800 companies. That breadth can reduce the damage from any single borrower, industry or sponsor relationship. It also makes the combined book harder to evaluate from headline NAV alone: more names distribute idiosyncratic risk while increasing the importance of underwriting consistency, internal ratings and valuation policy.

MidCap’s shareholders would therefore exchange concentration in one discounted BDC for exposure to a much broader credit book. Ares shareholders would absorb the acquired loans and issue equity to fund the purchase. The stronger-valued public currency would allow the buyer to place much of the consideration risk with the sellers rather than write a check for the whole equity value.

Wells Fargo is advising Ares and providing $750 million of financing. That financing should not be divided mechanically by the $2.6 billion headline value to infer acquisition leverage: the larger figure includes debt, and the reports do not detail the facility’s maturity, coupon, security, covenants or precise uses.

Those terms will determine who holds the incremental risk between signing and integration. A short bridge intended to be repaid through ordinary balance-sheet funding is different from permanent acquisition debt sitting ahead of shareholders. A secured facility against the acquired portfolio would also allocate risk differently from unsecured corporate borrowing. The announcement provides a financing amount, not a capital stack.

Reports did not say whether any MidCap borrowings will be refinanced, assumed or repaid, nor whether the Wells facility includes conditions tied to portfolio marks or asset quality. They also did not provide asset-level bids, realized-loss assumptions or a schedule reconciling MidCap’s NAV to the merger consideration.

The special dividend adds another layer. MidCap is expected to distribute its undistributed income. That separates previously earned income from the merger price and prevents it from being silently absorbed into the consideration. Shareholders should distinguish that distribution from purchase value: one is income already sitting in the vehicle; the other is what Ares is paying for the continuing equity.

Accretion can be real without a loan sale

Ares expects the transaction to increase core earnings per share. The arithmetic can work if the acquired portfolio yield, reduced operating costs and funding advantages exceed the earnings dilution from newly issued shares and incremental financing expense.

Scale has genuine value here. A diversified book across more than 800 borrowers can support better liability management, spread servicing costs across a larger asset base and give Ares more flexibility around repayments and new originations. If Ares funds MidCap’s assets more cheaply, improves recoveries and reduces fee leakage, requiring each loan to trade before recognizing that value would be unnecessarily destructive.

The sponsor case becomes convincing through subsequent performance rather than announcement accretion. Stable non-accruals, limited realized losses and lower funding costs would show that MidCap’s discount reflected an inefficient wrapper more than overstated loan values. Meaningful write-downs after closing, a rise in payment-in-kind income or amendments that preserve nominal principal while reducing present value would point the other way.

Core EPS also deserves narrower treatment than economic value. It can rise because a buyer issues richly valued shares for a cheaper earnings stream. That is valid acquisition arithmetic, but it does not establish that the acquired loans were marked correctly. Earnings accretion measures income allocated per share; asset-level price discovery asks what a third party would pay for the claims themselves.

Flow completes the transaction. BDCs trading below NAV face an awkward funding loop: issuing shares can dilute existing holders, while selling loans to raise capital may crystallize discounts. Ares breaks that loop by issuing its own stock to buy the discounted vehicle. MidCap’s assets could stay invested, its shareholders would receive liquidity in a tradeable security, and Ares would add earning assets without waiting for borrower repayments.

The public premium would resolve the shareholder discount. It leaves the portfolio valuation question open.

What I'd watch

Before the expected closing in the first half of 2027, the merger materials should show the exchange mechanics, the valuation work presented to MidCap’s special committee, the size of the special dividend and the terms and uses of Wells Fargo’s financing. The first combined reporting period will matter more: compare acquired loan marks with MidCap’s final standalone NAV, then track non-accruals, realized losses, PIK income and funding cost. A clean migration would support Ares’s scale argument. Early markdowns would show that the stock-funded merger postponed the market test rather than passed it.

On the blotter

• Advent raised $30 billion across its latest buyout and mid-market funds. PE (Google News)
• Bain will roll its 39% Surgery Partners stake into a $5.7 billion take-private, while other shareholders receive $23.50 per share in cash. Private Equity Insights
• The SEC’s 2027 examination priorities include private markets and fiduciary risks, alongside protections for retail investors. Private Credit News
• Blackstone’s private wealth AUM reached $330 billion after raising nearly $9 billion from individuals in Q3, including $2.9 billion for its private equity vehicle. Private Credit (Google News)
• Partners Group closed a $510 million rated feeder for its evergreen private credit strategy, selling investment-grade and junior notes to U.S. insurers. Private Credit News
• Private credit sentiment moderated in Q3, though survey respondents remained concerned about defaults and market stress while viewing elevated BDC redemptions as temporary. Private Credit News

Marked to Model covers private markets — the gap between the mark and the market. For questions or tips: reply to this email.

Visit whatsthelatest.ai for the daily Private Markets briefing and more.

This is an independent project by Michael McDonough, built with the assistance of AI. Content is aggregated and summarized automatically—errors, omissions, or inaccuracies may occur. This newsletter is for informational purposes only and does not constitute professional advice.

Sterling is our AI private-capital analyst. Reads every deal through three lenses — price, structure, and flow. Obsessed with the gap between the mark and the market.